Within the ongoing XRP lawsuit between the US Securities and Change Fee (SEC) and Ripple Labs, Inc., the SEC has formally requested a modification to the present schedule for remedies-related briefing. The request, directed to Choose Analisa Torres of the Southern District of New York, seeks a one-week extension throughout a number of deadlines, citing “good cause” underneath Federal Rule of Civil Process 16(b)(4) for the requested changes.

XRP Lawsuit: SEC Seeks Deadline Extension

The SEC’s petition, submitted on February 27, 2024, outlines a proposed delay within the deadlines for submitting all events’ briefs associated to the cures part of the case. Particularly, the SEC has requested that its deadline for submitting the remedies-related opening temporary be moved from March 13 to March 22, 2024.

Consequently, Ripple’s deadline to file its opposition temporary would shift from April 12 to April 22, 2024, and the deadline for the SEC to submit its reply temporary would lengthen from April 29 to Might 6, 2024.

#XRPCommunity #SECGov v. #Ripple #XRP @SECGov has requested a change to the cures briefing deadlines, asking that: (1) the @SECGov’s opening temporary deadline be prolonged to March 22, 2024, (2) @Ripple’s deadline to file its opposition temporary be prolonged to April 22, 2024, and (3)… pic.twitter.com/ZvCixNdLMm

— James Okay. Filan 🇺🇸🇮🇪 (@FilanLaw) February 28, 2024

Within the letter, Jorge G. Tenreiro, on behalf of the SEC, acknowledged, “None of the parties has previously requested an extension of the remedies-related briefing schedule. Ripple consents to the SEC’s request.” This consensus between the events underscores the collaborative side of navigating the procedural complexities of the case.

The SEC justified its request by referring to a current dispute over discovery’s scope, resolved solely by February 5, 2024. As Bitcoinist reported, Ripple was ordered on this present day to share monetary statements to evaluate if post-lawsuit institutional XRP gross sales breached securities legal guidelines.

The SEC argues that this delay necessitates a one-week extension of the remedies-related discovery interval. “Notwithstanding these efforts, a dispute between the parties as to the proper scope of discovery was not resolved until February 5, 2024,” Tenreiro defined, emphasizing the unexpected delay’s impression on the briefing schedule.

Furthermore, Tenreiro highlighted the SEC’s diligence and the mutual settlement between the events as key elements supporting the request for extension, arguing that it permits for a extra thorough assessment of the not too long ago produced paperwork and the finalization of the briefing.

“The SEC has been diligent in completing remedies-related discovery and briefing,” he famous, including that “Ripple, who consents to the SEC’s request, would not be unfairly prejudiced by the SEC having nine additional days to file its opening brief.”

The SEC’s letter additionally clarifies that the trial’s imminence doesn’t affect the request, given the absence of a pending trial within the remaining proceedings. This element factors to the procedural nature of the extension request, relatively than any substantive delay within the decision of the case itself.

Within the XRP lawsuit, the “remedies” part refers to potential actions or penalties imposed by the SEC as a consequence of alleged unlawful actions by Ripple, significantly regarding the unregistered sale of XRP.

John Deaton, a pro-XRP lawyer, predicts that Ripple’s high-quality might be decrease than its authorized charges, probably starting from $10 million to $100 million. This stems from allegations that Ripple violated securities legal guidelines by promoting $770 million price of XRP.

At press time, XRP traded at $0.5795.